// App-Quantinova.ai

1280 : Associations Between Sirolimus Use and Outcomes After Liver Transplant for Hepatocellular Carcinoma

Researchers

Presenter

  • E. Yanik

Principal Investigators

  • S. Chinnakotla

  • A. Israni

  • J. Snyder

  • S. Gustafson

  • E. Engels

Medical Centers

  • U. of Minnesota, Minneapolis, MN

  • National Cancer Institute, Bethesda, MD

  • Sci. Reg. of Transplant Recipients, Minneapolis, MN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Hepatitis C

  • Solid malignancies

Biomarkers

  • Alpha-fetoprotein

  • Serine/threonine-protein kinase mTOR

Drug/Treatment

  • Alfa-fetoprotein

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved